Hepsen Mine Serin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hepsen Mine Serin has a total of 235 co-authors. Here are the top co-authors by number of shared publications:
- Hasan Tekgül
Division of Pediatric Neurology, Department of Pediatrics, Ege University Faculty of Medicine, Izmir, Turkiye
13 shared publications - Seda Kanmaz
Department of Pediatric Neurology, Faculty of Medicine, Ege University, Izmir, Turkey
13 shared publications - Erdem Simsek
Ege University Faculty of Medicine, Department of Pediatrics, Division of Child Neurology, Izmir, Turkiye
12 shared publications - Sanem Yilmaz
Department of Pediatrics, Division of Child Neurology, Ege University Medical Faculty, Turkey
12 shared publications - Sarenur Gökben
Department of Pediatrics, Division of Child Neurology Ege University Medical Faculty İzmir Turkey
10 shared publications - Gul Aktan
Department of Pediatrics, Division of Child Neurology, Ege University Medical Faculty, Turkiye
9 shared publications
Latest Publications
- 7 January 2025
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 54, 89-95
Etiology-specific subgroup analysis of initial pharmacotherapy in infantile epileptic spasm syndrome: A single-center cohort study
- 7 January 2025
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 54, 89-95
Etiology-specific subgroup analysis of initial pharmacotherapy in infantile epileptic spasm syndrome: A single-center cohort study
- Open Access
- 25 August 2023
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 58 (5) , 509-514
Adaptability of Pediatric Residents for the International League Against Epilepsy-2017 Seizure Classification with a Modular Education Program
Objective: The aim of this study was to evaluate the adaptability of pediatric residents to the current seizure classification of the International League Against Epilepsy-2017 (ILAE-2017) using a modular education program (MEP). Materials and Methods: The MEP design consisted of 8 modules, including 5 modules for the current version of the ILAE-2017 seizure classification and 3 modules for the older ILAE-1981 version. The MEP was implemented with a group of pediatric residents, and it comprised 50 illustrative pediatric seizure videos along with an instruction manual kit that included a seizure determinator. Following a 3-month follow-up period, a posttest was conducted using 58 new videos in the MEP. Results: The overall success rates of the participants were similar both ILAE-2017 (41%) and ILAE-1981 (38.5%) seizure classifications in the post-MEP test. Regarding the ILAE-2017 mod- ules, the participants demonstrated a higher proficiency in classifying focal nonmotor seizures (56.3%) compared to focal motor seizures (34.9%). However, when it came to generalized seizures, the participants had significantly lower accuracy rates for generalized nonmotor seizures (26%) compared to generalized motor seizures (46%) with the ILAE-2017 classifica- tion. The seizure types that were most commonly misclassified, with an error rate exceeding 50%, were automatisms and myoclonic seizures within the focal seizure modules and atypical absences in generalized seizure modules of ILAE-2017. Conclusion: The single-day MEP yielded modest results, with a success rate of 41% in terms of the initial adaptability of pediatric residents to the ILAE-2017 seizure classification. However, to ensure successful implementation of the ILAE-2017 classification in clinical practice, additional booster applications of the MEP are required. Cite this article as: İmanli M, Şimşek E, Dezhakam A, et al. Adaptability of pediatric residents for the International League Against Epilepsy-2017 seizure classification with a modular education program. Turk Arch Pediatr. 2023;58(5):509-514.
- 25 August 2023
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 58 (5) , 509-514
Open AccessAdaptability of Pediatric Residents for the International League Against Epilepsy-2017 Seizure Classification with a Modular Education Program
Objective: The aim of this study was to evaluate the adaptability of pediatric residents to the current seizure classification of the International League Against Epilepsy-2017 (ILAE-2017) using a modular education program (MEP). Materials and Methods: The MEP design consisted of 8 modules, including 5 modules for the current version of the ILAE-2017 seizure classification and 3 modules for the older ILAE-1981 version. The MEP was implemented with a group of pediatric residents, and it comprised 50 illustrative pediatric seizure videos along with an instruction manual kit that included a seizure determinator. Following a 3-month follow-up period, a posttest was conducted using 58 new videos in the MEP. Results: The overall success rates of the participants were similar both ILAE-2017 (41%) and ILAE-1981 (38.5%) seizure classifications in the post-MEP test. Regarding the ILAE-2017 mod- ules, the participants demonstrated a higher proficiency in classifying focal nonmotor seizures (56.3%) compared to focal motor seizures (34.9%). However, when it came to generalized seizures, the participants had significantly lower accuracy rates for generalized nonmotor seizures (26%) compared to generalized motor seizures (46%) with the ILAE-2017 classifica- tion. The seizure types that were most commonly misclassified, with an error rate exceeding 50%, were automatisms and myoclonic seizures within the focal seizure modules and atypical absences in generalized seizure modules of ILAE-2017. Conclusion: The single-day MEP yielded modest results, with a success rate of 41% in terms of the initial adaptability of pediatric residents to the ILAE-2017 seizure classification. However, to ensure successful implementation of the ILAE-2017 classification in clinical practice, additional booster applications of the MEP are required. Cite this article as: İmanli M, Şimşek E, Dezhakam A, et al. Adaptability of pediatric residents for the International League Against Epilepsy-2017 seizure classification with a modular education program. Turk Arch Pediatr. 2023;58(5):509-514.
- 1 April 2023
- Published by Wiley in Epileptic Disorders
- Vol. 25 (2) , 218-228
What are the predominant predictors of seizure relapse following discontinuation of anti‐seizure medication in epileptic children?
Objective: The aim of the study was to identify the predominant predictors of seizure relapse following discontinuation of ASM in epileptic children.Methods: The study cohort consisted of 403 epileptic children who had a withdrawal process of ASM (monotherapy: 344; dual therapy or polytherapy: 59) after at least a 2‐year seizure‐free period. Patients were categorized if they had a well‐defined epileptic syndrome. Epileptic children with ongoing ketogenic diet, vagal nerve stimulation, or surgery were excluded from the cohort due to the additional withdrawal process related to other therapy modalities.Results: The cohort's seizure relapse rate was 12.7% (51/403). The highest rates of seizure relapse were defined for genetic etiology at 25% and structural etiology at 14.9%. An epilepsy syndrome was defined in 183 of 403 children (45.4%). There was no difference in the seizure relapse rate between the subgroups of well‐defined epileptic syndromes; 13.8% for self‐limited focal epileptic syndromes, 11.7% for developmental and epileptic encephalopathies, and 7.1% for generalized epileptic syndromes. Five predictors were defined as the most powerful predictors of seizure relapse in univariate analysis: age at epilepsy diagnosis >2 years (hazard ratio [HR]: 1.480; 95% confidence interval [CI]: 1.134–1.933), defined etiology (HR: 1.304; 95% CI: 1.003–1.696), focal seizure (HR: 1.499; 95% CI: 1.209–1.859), ≤3 months duration of the withdrawal process (HR: 1.654; 95% CI: 1.322–2.070), and a history of neonatal encephalopathy with or without seizures (HR: 3.140; 95% CI: 2.393–4.122). In multivariate analysis, the main predictor of seizure relapse was a history of neonatal encephalopathy with or without seizures (HR: 2.823; 95% CI: 2.067–3.854).Significance: The duration of seizure freedom before discontinuation of ASM was not a predominant risk factor for seizure relapse: 2–3 years versus >3 years. The predictive values of five predictors of seizure relapse rate should be evaluated for patients with different epilepsy subgroups.
- 1 April 2023
- Published by Wiley in Epileptic Disorders
- Vol. 25 (2) , 218-228
What are the predominant predictors of seizure relapse following discontinuation of anti‐seizure medication in epileptic children?
Objective: The aim of the study was to identify the predominant predictors of seizure relapse following discontinuation of ASM in epileptic children.Methods: The study cohort consisted of 403 epileptic children who had a withdrawal process of ASM (monotherapy: 344; dual therapy or polytherapy: 59) after at least a 2‐year seizure‐free period. Patients were categorized if they had a well‐defined epileptic syndrome. Epileptic children with ongoing ketogenic diet, vagal nerve stimulation, or surgery were excluded from the cohort due to the additional withdrawal process related to other therapy modalities.Results: The cohort's seizure relapse rate was 12.7% (51/403). The highest rates of seizure relapse were defined for genetic etiology at 25% and structural etiology at 14.9%. An epilepsy syndrome was defined in 183 of 403 children (45.4%). There was no difference in the seizure relapse rate between the subgroups of well‐defined epileptic syndromes; 13.8% for self‐limited focal epileptic syndromes, 11.7% for developmental and epileptic encephalopathies, and 7.1% for generalized epileptic syndromes. Five predictors were defined as the most powerful predictors of seizure relapse in univariate analysis: age at epilepsy diagnosis >2 years (hazard ratio [HR]: 1.480; 95% confidence interval [CI]: 1.134–1.933), defined etiology (HR: 1.304; 95% CI: 1.003–1.696), focal seizure (HR: 1.499; 95% CI: 1.209–1.859), ≤3 months duration of the withdrawal process (HR: 1.654; 95% CI: 1.322–2.070), and a history of neonatal encephalopathy with or without seizures (HR: 3.140; 95% CI: 2.393–4.122). In multivariate analysis, the main predictor of seizure relapse was a history of neonatal encephalopathy with or without seizures (HR: 2.823; 95% CI: 2.067–3.854).Significance: The duration of seizure freedom before discontinuation of ASM was not a predominant risk factor for seizure relapse: 2–3 years versus >3 years. The predictive values of five predictors of seizure relapse rate should be evaluated for patients with different epilepsy subgroups.
- Open Access
- 1 March 2023
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 58 (2) , 142-153
Assessment of Prognostic Factors and Validity of Scoring Models in Childhood Autoimmune Encephalitis
Objective: The aim of this study is to evaluate the prognostic factors in a single-center pediatric cohort with autoimmune encephalitis. Materials and Methods: The study group consisted of 23 pediatric autoimmune encephalitis patients (seropositive autoimmune encephalitis: 15, seronegative autoimmune encephalitis: 8). Five group prognostic parameters were evaluated: clinical manifestations, elect roenc ephal ograp hy features, magnetic resonance imaging characteristics, biomarkers, and treatment modalities. Three scoring models were applied: the Antibody Prevalence in Epilepsy and Response to Immunotherapy in Epilepsy for predicting autoimmune-related epilepsy in the whole cohort and the anti-N-methyl-d-aspartate receptor Encephalitis 1-Year Functional Status score for overall outcome in patients with anti-N-methyl-d-aspartate receptor encephalitis. Results: The initial clinical spectrum of the disease was similar in the seronegative and seropositive groups. Almost half of the patients (48%) recovered without any complications with first-line immunotherapy. The patients with movement disorders in the acute phase of the disease needed more likely second-line immunotherapy (P = .039). The presence of status epilepticus at admission was significantly associated with adverse outcomes and the development of autoimmune-related epilepsy (P = .019). Autoimmune-related epilepsy was defined in an equal proportion of patients (91.5%) with 2 immune epilepsy scores (Antibody Prevalence in Epilepsy and Response to Immunotherapy in Epilepsy). The N-methyl-d-aspartate receptor Encephalitis 1-Year Functional Status score and the modified Rankin score assessed for the first-year prognosis were strongly correlated among the patients with anti-N-methyl-d-aspartate receptor encephalitis (P = .03, Spearmen’s rho = 0.751). Conclusions: The presence of status epilepticus was the most important prognostic factor in the patients with the adverse outcome. The studied scoring models (Anti-N-methyl-d-aspartate receptor Encephalitis 1-Year Functional Status, Antibody Prevalence in Epilepsy, and Response to Immunotherapy in Epilepsy) have also been proven to be applicable to the pediatric age group for predicting overall outcome and autoimmune-related epilepsy. Cite this article as: Kanmaz S, Yılmaz S, Toprak DE, et al. Assessment of prognostic factors and validity of scoring models in childhood autoimmune encephalitis. Turk Arch Pediatr. 2023;58(2):142-153.
- 1 March 2023
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 58 (2) , 142-153
Open AccessAssessment of Prognostic Factors and Validity of Scoring Models in Childhood Autoimmune Encephalitis
Objective: The aim of this study is to evaluate the prognostic factors in a single-center pediatric cohort with autoimmune encephalitis. Materials and Methods: The study group consisted of 23 pediatric autoimmune encephalitis patients (seropositive autoimmune encephalitis: 15, seronegative autoimmune encephalitis: 8). Five group prognostic parameters were evaluated: clinical manifestations, elect roenc ephal ograp hy features, magnetic resonance imaging characteristics, biomarkers, and treatment modalities. Three scoring models were applied: the Antibody Prevalence in Epilepsy and Response to Immunotherapy in Epilepsy for predicting autoimmune-related epilepsy in the whole cohort and the anti-N-methyl-d-aspartate receptor Encephalitis 1-Year Functional Status score for overall outcome in patients with anti-N-methyl-d-aspartate receptor encephalitis. Results: The initial clinical spectrum of the disease was similar in the seronegative and seropositive groups. Almost half of the patients (48%) recovered without any complications with first-line immunotherapy. The patients with movement disorders in the acute phase of the disease needed more likely second-line immunotherapy (P = .039). The presence of status epilepticus at admission was significantly associated with adverse outcomes and the development of autoimmune-related epilepsy (P = .019). Autoimmune-related epilepsy was defined in an equal proportion of patients (91.5%) with 2 immune epilepsy scores (Antibody Prevalence in Epilepsy and Response to Immunotherapy in Epilepsy). The N-methyl-d-aspartate receptor Encephalitis 1-Year Functional Status score and the modified Rankin score assessed for the first-year prognosis were strongly correlated among the patients with anti-N-methyl-d-aspartate receptor encephalitis (P = .03, Spearmen’s rho = 0.751). Conclusions: The presence of status epilepticus was the most important prognostic factor in the patients with the adverse outcome. The studied scoring models (Anti-N-methyl-d-aspartate receptor Encephalitis 1-Year Functional Status, Antibody Prevalence in Epilepsy, and Response to Immunotherapy in Epilepsy) have also been proven to be applicable to the pediatric age group for predicting overall outcome and autoimmune-related epilepsy. Cite this article as: Kanmaz S, Yılmaz S, Toprak DE, et al. Assessment of prognostic factors and validity of scoring models in childhood autoimmune encephalitis. Turk Arch Pediatr. 2023;58(2):142-153.
- 1 September 2022
- Published by Galenos Yayinevi in The Journal of Pediatric Research
- Vol. 9 (3) , 228-235
Continuous EEG Monitoring in Critically Ill Children and Prognostic Factors for Short-term Outcome: An Observational Study
- 1 September 2022
- Published by Galenos Yayinevi in The Journal of Pediatric Research
- Vol. 9 (3) , 228-235
Continuous EEG Monitoring in Critically Ill Children and Prognostic Factors for Short-term Outcome: An Observational Study
- 6 June 2022
- Published by Elsevier in Epilepsy Research
- Vol. 184, 106963
The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study
- 6 June 2022
- Published by Elsevier in Epilepsy Research
- Vol. 184, 106963
The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study
- 4 March 2022
- Published by Taylor & Francis in Neurocase
- Vol. 28 (2) , 239-245
Understanding and management of anti-N-methyl-D-aspartate receptor encephalitis from a child psychiatry perspective: report of five cases
Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a rare autoimmune entity in psychiatry literature that occurs when antibodies attack NMDA-type glutamate receptors in the brain. Principle clinical features include a neurological domain such as seizure, orofacial dyskinesia, dystonia, and choreic-like movements of extremities. Also the psychiatric manifestations of this form of encephalitis may vary from psychotic-like symptoms to mood symptoms like depression or mania. Herein we report on five female child cases diagnosed with anti-NMDAR encephalitis, presented with both neurological and psychiatric clinical picture, and highlight the trajectory of disorder from a psychiatric perspective.
- 4 March 2022
- Published by Taylor & Francis in Neurocase
- Vol. 28 (2) , 239-245
Understanding and management of anti-N-methyl-D-aspartate receptor encephalitis from a child psychiatry perspective: report of five cases
Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a rare autoimmune entity in psychiatry literature that occurs when antibodies attack NMDA-type glutamate receptors in the brain. Principle clinical features include a neurological domain such as seizure, orofacial dyskinesia, dystonia, and choreic-like movements of extremities. Also the psychiatric manifestations of this form of encephalitis may vary from psychotic-like symptoms to mood symptoms like depression or mania. Herein we report on five female child cases diagnosed with anti-NMDAR encephalitis, presented with both neurological and psychiatric clinical picture, and highlight the trajectory of disorder from a psychiatric perspective.
- 1 January 2022
- Published by Academician Publishing
Temel Pediatrik Nöroloji: Tanı ve Tedavi 4. Cilt
Erciyes Üniversitesi Tıp Fakültesi Çocuk Nörolojisi Bölümünden Prof. Dr. Sefer Kumandaş’ın önderliğinde 500’den fazla yazarın katkısı ile 361 bölüm 4576 sayfa tutan bir Çocuk Nörolojisi kitabının sadece İÇİNDEKİLER listesini gördükten sonra izlenimlerimizi sizlerle paylaşmak istedik. Çocuk Nörolojisi kapsamı içine giren konuların bu kadar fazla olması eğitiminin zorluğunu işaret ettiği gibi kitaptaki konuların okunabilir, öğrenilebilir, faydalanılabilir ve geçerliliğinin de bir göstergesi olacaktır. Tıbbi konularda Türkçe yayınların dünya literatürü ile kıyaslanabilir bir düzeye gelmesi hepimizin hedefi olmalıdır.
- 1 January 2022
- Published by Academician Publishing
Temel Pediatrik Nöroloji: Tanı ve Tedavi 4. Cilt
Erciyes Üniversitesi Tıp Fakültesi Çocuk Nörolojisi Bölümünden Prof. Dr. Sefer Kumandaş’ın önderliğinde 500’den fazla yazarın katkısı ile 361 bölüm 4576 sayfa tutan bir Çocuk Nörolojisi kitabının sadece İÇİNDEKİLER listesini gördükten sonra izlenimlerimizi sizlerle paylaşmak istedik. Çocuk Nörolojisi kapsamı içine giren konuların bu kadar fazla olması eğitiminin zorluğunu işaret ettiği gibi kitaptaki konuların okunabilir, öğrenilebilir, faydalanılabilir ve geçerliliğinin de bir göstergesi olacaktır. Tıbbi konularda Türkçe yayınların dünya literatürü ile kıyaslanabilir bir düzeye gelmesi hepimizin hedefi olmalıdır.
- 1 January 2022
- Published by Wiley in Pediatrics International
- Vol. 64 (1) , e15005
Evaluation of micronutrient levels in children with cerebral palsy
Background: Many studies evaluating the nutritional status of children with cerebral palsy (CP) have focused on energy requirements and protein intake. The present work aimed to assess nutritional status and micronutrient levels of children with (CP). Methods: This multicenter, cross‐sectional and observational study was conducted in 10 different cities in Turkey. Data were available for 398 participants. Anthropometric measurements, feeding mode, nutritional status, and micronutrient levels were evaluated. Results: The study was conducted with 398 participants (303 patients and 95 healthy controls). Statistical analysis showed that according to the Gomez Classification, weight‐for‐age (WFA) revealed malnutrition in 92.6% of children with CP, based on Centers for Disease Control and Prevention percentiles. Measurements of micronutrient levels showed that zinc levels were low in patients, whereas vitamin A levels were low in controls. Phosphorous and manganese levels were significantly lower in malnourished children than in typical children. The results revealed that children consuming enteral nutrition solutions had higher selenium and lower zinc levels than non‐consumers. Conclusions: Malnutrition is not only a protein‐ or calorie‐based problem; micronutrient deficiencies might cause severe health problems. Children with chronic neurological disabilities must be carefully evaluated for these issues. Therefore, nutritional interventions should be adapted to nutrition.
- 1 January 2022
- Published by Wiley in Pediatrics International
- Vol. 64 (1) , e15005
Evaluation of micronutrient levels in children with cerebral palsy
Background: Many studies evaluating the nutritional status of children with cerebral palsy (CP) have focused on energy requirements and protein intake. The present work aimed to assess nutritional status and micronutrient levels of children with (CP). Methods: This multicenter, cross‐sectional and observational study was conducted in 10 different cities in Turkey. Data were available for 398 participants. Anthropometric measurements, feeding mode, nutritional status, and micronutrient levels were evaluated. Results: The study was conducted with 398 participants (303 patients and 95 healthy controls). Statistical analysis showed that according to the Gomez Classification, weight‐for‐age (WFA) revealed malnutrition in 92.6% of children with CP, based on Centers for Disease Control and Prevention percentiles. Measurements of micronutrient levels showed that zinc levels were low in patients, whereas vitamin A levels were low in controls. Phosphorous and manganese levels were significantly lower in malnourished children than in typical children. The results revealed that children consuming enteral nutrition solutions had higher selenium and lower zinc levels than non‐consumers. Conclusions: Malnutrition is not only a protein‐ or calorie‐based problem; micronutrient deficiencies might cause severe health problems. Children with chronic neurological disabilities must be carefully evaluated for these issues. Therefore, nutritional interventions should be adapted to nutrition.
- 17 May 2021
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 123 (1) , 121-127
Cerebral folate transporter deficiency: a potentially treatable neurometabolic disorder
Cerebral folate deficiency (CFD) syndrome is a rare treatable neurometabolic disorder with low levels of the active form of folaten in cerebrospinal fluid (CSF) arising from different causes such as FOLR1 gene mutations or autoantibodies against the folate receptor-alpha (FR) protein that can block folate transport across the choroid plexus. It is characterized by late infantile onset refractory seizures, ataxia, movement disorder, and unexplained global developmental delay. Here, we report a patient diagnosed with autistic spectrum disorder, followed by refractory myoclonic-atonic seizures, ataxia, and loss of motor skills over time. A homozygous missense (c.665A > G) mutation in FOLR1 gene and extremely low CSF 5-methyltetrahydrofolate level led to the diagnosis of CFD. Although she was initiated on combined oral and intravenous high doses of folinic acid treatment at 6 years of age, mild improvement was achieved in terms of epileptic seizures and motor skills. It is important that CFD should be kept in mind in cases with refractory myoclonic-atonic seizure and folinic acid treatment should be started as soon as possible.
- 17 May 2021
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 123 (1) , 121-127
Cerebral folate transporter deficiency: a potentially treatable neurometabolic disorder
Cerebral folate deficiency (CFD) syndrome is a rare treatable neurometabolic disorder with low levels of the active form of folaten in cerebrospinal fluid (CSF) arising from different causes such as FOLR1 gene mutations or autoantibodies against the folate receptor-alpha (FR) protein that can block folate transport across the choroid plexus. It is characterized by late infantile onset refractory seizures, ataxia, movement disorder, and unexplained global developmental delay. Here, we report a patient diagnosed with autistic spectrum disorder, followed by refractory myoclonic-atonic seizures, ataxia, and loss of motor skills over time. A homozygous missense (c.665A > G) mutation in FOLR1 gene and extremely low CSF 5-methyltetrahydrofolate level led to the diagnosis of CFD. Although she was initiated on combined oral and intravenous high doses of folinic acid treatment at 6 years of age, mild improvement was achieved in terms of epileptic seizures and motor skills. It is important that CFD should be kept in mind in cases with refractory myoclonic-atonic seizure and folinic acid treatment should be started as soon as possible.